True, but they are approved for very high trigs...so I ruled that out. I think we'll see a Vascepa label change soon...it may not be approval of Anchor per se, but effectly Vascepa will have a clear label for Trigs>150 in high risk patients.
This also may be the reason why the appeal hasn't been officially taken to the next level.
Just speculation and trying to make some early calls.
News 
Market Data 
Discover 
